Cargando…
Metabolic dysfunction in polycystic ovary syndrome: Pathogenic role of androgen excess and potential therapeutic strategies
BACKGROUND: Polycystic ovary syndrome (PCOS) is the most common endocrinopathy among reproductive age women. Although its cardinal manifestations include hyperandrogenism, oligo/anovulation, and/or polycystic ovarian morphology, PCOS women often display also notable metabolic comorbidities. An array...
Autores principales: | Sanchez-Garrido, Miguel A., Tena-Sempere, Manuel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7115104/ https://www.ncbi.nlm.nih.gov/pubmed/32244180 http://dx.doi.org/10.1016/j.molmet.2020.01.001 |
Ejemplares similares
-
Implicating androgen excess in propagating metabolic disease in polycystic ovary syndrome
por: Kempegowda, Punith, et al.
Publicado: (2020) -
Association of Androgen Excess with Glucose Intolerance in Women with Polycystic Ovary Syndrome
por: Zhang, Bingjie, et al.
Publicado: (2018) -
Elevated and diagnostic androgens of polycystic ovary syndrome
por: Abdelazim, Ibrahim A., et al.
Publicado: (2020) -
Sexual function in women with androgen excess disorders: classic forms of congenital adrenal hyperplasia and polycystic ovary syndrome
por: Kępczyńska-Nyk, A., et al.
Publicado: (2020) -
Androgen Excess Induced Mitochondrial Abnormality in Ovarian Granulosa Cells in a Rat Model of Polycystic Ovary Syndrome
por: Song, Linyi, et al.
Publicado: (2022)